QQ客服 官方微博 反馈留言

	Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study
	Robertson, Michael N.; Wei, Lai; Jia, Ji Dong; Wang, Fu Sheng; Niu, Jun Qi; Zhao, Xu Min; Mu, Shengmei; Liang, Li Wen; Wang, Zaiqi; Hwang, Peggy
刊名	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
	2019
卷号	34期号:1
关键词	HCV clinical trials HCV treatment hepatitis C, clinical
ISSN号	0815-9319
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3535037
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Robertson, Michael N.,Wei, Lai,Jia, Ji Dong,et al. Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,2019,34(1).
APA	Robertson, Michael N..,Wei, Lai.,Jia, Ji Dong.,Wang, Fu Sheng.,Niu, Jun Qi.,...&George, Jacob.(2019).Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,34(1).
MLA	Robertson, Michael N.,et al."Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study".JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 34.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。